Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
School of Pharmaceutical Sciences,
Center for Cellular & Structural Biology
Jieyu Xing has not added Biography.
If you are Jieyu Xing and would like to personalize this page please email our Author Liaison for assistance.
A targeted IL-15 fusion protein with potent anti-tumor activity.
Cancer biology & therapy , 2015 | Pubmed ID: 26176990
A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.
AMB Express Dec, 2016 | Pubmed ID: 27112931
BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells.
Translational oncology Oct, 2017 | Pubmed ID: 28797938
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.
International journal of nanomedicine , 2018 | Pubmed ID: 29881272
Sun Yat-sen University
Yanlan Wang1,2,
Jiayu Liu1,2,
Haitao Pan1,2,
Jieyu Xing1,2,
Xiaoqiong Wu1,2,
Qing Li1,2,
Zhong Wang1,2
1School of Pharmaceutical Sciences, Sun Yat-Sen University,
2Center for Cellular & Structural Biology, Sun Yat-Sen University
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados